Mark Alles
business executiveMale0.0Global Dominance: 0.00%
Mark Alles is a former executive at Celgene, the pharmaceutical company behind Revlimid, a derivative of thalidomide. Under his leadership, the company faced scrutiny for its aggressive pricing strategies while promoting the drug as a life-saving therapy for multiple myeloma.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Celgene President Mark Alles sent an internal email complaining of disappointing first quarter Revlimid sales.
The price of remission | CNNCNN·
United States· 2025-05-11
United States· 2025-05-11
